Coherus Oncology, Inc. Amortization of Intangible Assets
Coherus Oncology, Inc. (CHRS) reported Amortization of Intangible Assets of $600.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-05
- Coherus Oncology, Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $600.00K, a 0.00% change year-over-year.
- Coherus Oncology, Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $600.00K, a 14.29% decline year-over-year.
- Coherus Oncology, Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $600.00K, a 14.29% decline year-over-year.
- Coherus Oncology, Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $700.00K, a 36.36% decline year-over-year.
- Coherus Oncology, Inc. amortization of intangible assets for fiscal 2025 was $2.60M, a 23.53% decline from fiscal 2024.
- Coherus Oncology, Inc. amortization of intangible assets for fiscal 2024 was $3.40M.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $600.00K 10-Q · filed 2026-08-05 | $1.30M 10-Q · filed 2026-08-05 | $1.80M derived: sum of 3 quarters · filed 2026-08-05 | $2.50M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $600.00K 10-Q · filed 2026-05-11 | $1.20M derived: sum of 2 quarters · filed 2026-05-11 | $1.90M derived: sum of 3 quarters · filed 2026-05-11 | $2.50M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $1.30M derived: sum of 2 quarters · filed 2026-03-09 | $1.90M derived: sum of 3 quarters · filed 2026-08-05 | $2.60M 10-K · filed 2026-03-09 | ||
| 2025-09-30 | $700.00K 10-Q · filed 2025-11-06 | $1.30M derived: sum of 2 quarters · filed 2026-08-05 | $2.00M 10-Q · filed 2025-11-06 | $2.70M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | $600.00K 10-Q · filed 2026-08-05 | $1.30M 10-Q · filed 2026-08-05 | $2.00M derived: sum of 3 quarters · filed 2026-08-05 | $3.10M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $700.00K 10-Q · filed 2026-05-11 | $1.40M derived: sum of 2 quarters · filed 2026-05-11 | $2.50M derived: sum of 3 quarters · filed 2026-05-11 | $3.20M derived: sum of 4 quarters · filed 2026-05-11 | ||
| 2024-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $1.80M derived: sum of 2 quarters · filed 2026-03-09 | $2.50M derived: sum of 3 quarters · filed 2026-03-09 | $3.40M 10-K · filed 2026-03-09 | ||
| 2024-09-30 | $1.10M 10-Q · filed 2025-11-06 | $1.20M 10-Q · filed 2024-11-06 | $1.80M derived: sum of 2 quarters · filed 2025-11-06 | $2.70M 10-Q · filed 2025-11-06 | $2.80M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $700.00K 10-Q · filed 2025-08-07 | $1.60M 10-Q · filed 2025-08-07 | ||||
| 2024-03-31 | $900.00K 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |